Proteon Pharmaceuticals
PROTEON’S proprietary phage development platform contains tools and processes honed from more than 10 years of R&D experience in bacteriophages. The company’s products are developed using bioinformatics, Artificial Intelligence, genomic sequencing, materials engineering and molecular biology. They are targeting animal health markets as first application, especially for poultry and aquaculture. The supply of such phage-based products represents a huge step forward in eliminating the unnecessary use of antibiotics, while contributing to an enhanced on-farm productivity.